Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT01028053
Show Display Options
Rank Status Study
1 Completed
Has Results
Assess the Prognostic Usefulness of Flutemetamol (18F) Injection for Identifying Subjects With Amnestic Mild Cognitive Impairment Who Will Convert to Clinically Probable Alzheimer's Disease
Conditions: Mild Cognitive Impairment;   Alzheimer's Disease
Intervention: Drug: Flutemetamol (18F) Injection

Study has passed its completion date and status has not been verified in more than two years.